These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17503555)

  • 1. Intractable spastic cerebral palsy in children: a Dutch cost of illness study.
    Hoving MA; Evers SM; Ament AJ; van Raak EP; Vles JS;
    Dev Med Child Neurol; 2007 May; 49(5):397-8. PubMed ID: 17503555
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparing impact on the family and insurance coverage in children with cerebral palsy and children with another special healthcare need.
    Schaible B; Colquitt G; Caciula MC; Carnes A; Li L; Moreau N
    Child Care Health Dev; 2018 May; 44(3):370-377. PubMed ID: 29327378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal baclofen therapy in children with intractable spastic cerebral palsy: a cost-effectiveness analysis.
    Hoving MA; Evers SM; Ament AJ; van Raak EP; Vles JS;
    Dev Med Child Neurol; 2008 Jun; 50(6):450-5. PubMed ID: 18422682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cost-effective national health program.
    J Public Health Policy; 1983 Sep; 4(3):252-8. PubMed ID: 6415106
    [No Abstract]   [Full Text] [Related]  

  • 5. [Not Available].
    Prokop A; Prokop J
    Zentralbl Chir; 2017 Jun; 142(3):241-243. PubMed ID: 28641338
    [No Abstract]   [Full Text] [Related]  

  • 6. Disabled children: care, compassion, charity, costs.
    Bleck EE
    Dev Med Child Neurol; 1992 Mar; 34(3):189-90. PubMed ID: 1532782
    [No Abstract]   [Full Text] [Related]  

  • 7. Young children with cerebral palsy: families self-reported equipment needs and out-of-pocket expenditure.
    Bourke-Taylor H; Cotter C; Stephan R
    Child Care Health Dev; 2014 Sep; 40(5):654-62. PubMed ID: 23952344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to Hex et al. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs.
    Waldeyer R; Brinks R; Giani G
    Diabet Med; 2013 Apr; 30(4):502-3. PubMed ID: 23126636
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical expenditures attributable to cerebral palsy and intellectual disability among Medicaid-enrolled children.
    Kancherla V; Amendah DD; Grosse SD; Yeargin-Allsopp M; Van Naarden Braun K
    Res Dev Disabil; 2012; 33(3):832-40. PubMed ID: 22245730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Getting the cat back in the bag: reforming the way provinces manage drug expenditures to make them manageable.
    Levy AR; Gagnon YM
    Healthc Pap; 2002; 3(1):32-7; discussion 87-94. PubMed ID: 12811108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comments on Waldeyer et al. 'Response to Hex et al. Estimating the current and future costs for Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs'.
    Hex N; Taylor M; Bartlett C
    Diabet Med; 2013 Apr; 30(4):503-4. PubMed ID: 23331120
    [No Abstract]   [Full Text] [Related]  

  • 12. In-home supportive services for individuals with cerebral palsy in California.
    Houtrow A; Kang T; Newcomer R
    J Pediatr Rehabil Med; 2012; 5(3):187-95. PubMed ID: 23023251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Surcharge for ambulatory care. A study by the Bertelsmann Foundation in cleartext: the authors see in home care nursing an answer to the nursing shortage].
    Heinemeyer C
    Pflege Z; 2013 Jan; 66(1):8. PubMed ID: 23394048
    [No Abstract]   [Full Text] [Related]  

  • 14. Propaganda or the cost of innovation? Challenging the high price of new drugs.
    Ghinea N; Lipworth W; Kerridge I
    BMJ; 2016 Mar; 352():i1284. PubMed ID: 26968991
    [No Abstract]   [Full Text] [Related]  

  • 15. Outpatient drug expenditures and prescription policies for diseases with high cost to the National Health Insurance system in Taiwan.
    Lang HC; Lai MS; Chen GT
    J Formos Med Assoc; 2004 Apr; 103(4):280-5. PubMed ID: 15175823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Life care planning for the child with cerebral palsy.
    Katz RT; Johnson CB
    Phys Med Rehabil Clin N Am; 2013 Aug; 24(3):491-505. PubMed ID: 23910487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Health insurance expenses for children in the first five years of life - a cohort-based analysis].
    Reichert J; Schemken M; Manthei R; Steinbronn R; Bucher U; Albrecht M; Rüdiger M
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(7):451-60. PubMed ID: 24238022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A microcosting study of the surgical correction of upper extremity deformity in children with spastic cerebral palsy.
    Alewijnse JV; van Rooijen EM; Kreulen M; Smeulders MJ; Tan SS
    Dev Neurorehabil; 2017 Apr; 20(3):173-178. PubMed ID: 27055081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term costs of public long-term care insurance in Germany. Some guesstimates.
    Schmähl W; Rothgang H
    Dev Health Econ Public Policy; 1996; 5():180-222. PubMed ID: 10164419
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cost-benefit principle and cost containment].
    Krauth C; Schwartz FW
    Med Klin (Munich); 1998 Jan; 93(1):49-51. PubMed ID: 9505081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.